JODY HUSS, ACNP
Acute Care Nurse Practitioner · BLUE ASH, OH
Individual Active NPI 1881105013
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 379 | 191,944 | $11,450,335 | $5,677,596 | $4,511,231 |
| 2023 | 420 | 183,107 | $17,185,389 | $8,534,409 | $6,791,203 |
| 2022 | 229 | 115,397 | $10,637,487 | $5,379,132 | $4,285,285 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0485 | Injection, belatacept, 1 mg | 41,750 | $4 | $3 |
| J1306 | Injection, inclisiran, 1 mg | 16,188 | $12 | $9 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 13,650 | $18 | $14 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 9,300 | $20 | $16 |
| J0897 | Injection, denosumab, 1 mg | 5,940 | $25 | $19 |
| J2182 | Injection, mepolizumab, 1 mg | 5,000 | $30 | $24 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 4,620 | $11 | $8 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,850 | $42 | $34 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,810 | $44 | $35 |
| J3245 | Injection, tildrakizumab, 1 mg | 3,400 | $137 | $109 |
| J2357 | Injection, omalizumab, 5 mg | 3,270 | $38 | $30 |
| J0517 | Injection, benralizumab, 1 mg | 540 | $165 | $131 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Acute Care Nurse Practitioner | 363LA2100X | ✓ | APRN.CNP.022469 | OH |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Acute Care Nurse Practitioner providers in Ohio
- NPI 1063937696
- NPI 1154166585
- NPI 1487937488
- NPI 1104559897
- NPI 1861277303
- NPI 1073491049
- NPI 1013646371
- NPI 1649345778
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.